NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Has anyone on this MB estimated what is Sawaton's current annual
DCVax-L artisan manufacturing capacity?
If there is a delay in the validation of the EDENs units, can the artisan
manufacturing capacity handle for even a few months an annual case load
equivalent to about 3200 new GBM cases and additional cases of glioma
grade 3 cases as well.

I hope that Sawston does have that capacity but that implies that many more
clean rooms have been made available. I am wondering about the money
spent on the conversion to clean rooms especially since once the EDEN system
is in place, those rooms are no longer needed.

Actually I am fairly certain that NWBO took all the above mentioned items
into account before submitting their MAA but am just wondering how they did it.

All logical responses are welcome.